This information was published on 2025-02-14T13:34:15 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2345587 (IR 1722068) |
| (220) |
27 Oct 2022
|
| (300) |
US, 27 Apr 2022, 97385224
US, 12 Oct 2022, 97629755 |
| (511) (510) |
Class 5
Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), autoimmune disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), inflammatory disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), diabetes, cancer, periodontal disease, blood disorders, pain, inflammation (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), sepsis, alopecia, obesity and cognitive disorders; pharmaceutical, medicinal and biological preparations for the treatment and prevention of orthopedic diseases and disorders; none of the foregoing goods being in the nature of nutraceuticals. Class 42 Medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), autoimmune disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), inflammatory disease (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), diabetes, cancer, periodontal disease, blood disorders, pain, inflammation (not relating to hay fever, stomach ulcers, digestive disorders, cardiological conditions or tissue wounds), sepsis, alopecia, obesity and cognitive disorders; none of the foregoing services being in respect of treatments or products involving quince or in respect of nutraceuticals. |
| (540) | QUINCE |
| (550) | Word |
| (730) |
Quince Therapeutics, Inc.
|
| (750) |
Allens Patent & Trade Mark Attorneys
|
Find out more about publications on the About page.